Diagnosis and treatment of cholangiocarcinoma: A consensus from surgical specialists of China

被引:17
|
作者
Cai, Jian-qiang [1 ]
Cai, Shou-wang [2 ]
Cong, Wen-ming [3 ]
Chen, Min-shan [4 ]
Chen, Ping [5 ]
Chen, Xiao-ping [6 ]
Chen, Yan-ling [7 ]
Chen, Yi-fa [6 ]
Dai, Chao-liu [8 ]
Huang, Qiang [9 ]
Huang, Zhi-yong [6 ]
Jiang, Bo [10 ]
Jiang, Bin [11 ]
Jiang, Ke-wei [12 ]
Li, Bo [13 ]
Li, Zong-fang [14 ]
Liang, Li-jian [15 ]
Liu, Bin [16 ]
Liu, Hui-chun [17 ]
Liu, Lian-xin [18 ]
Liu, Qing-guang [19 ]
Liu, Rong [2 ]
Liu, Ying-bin [20 ]
Lu, Jian-guo [21 ]
Lu, Shi-chun [2 ]
Lu, Yi [19 ]
Mao, Yi-lei [22 ]
Mei, Bin [6 ]
Niu, Jun [23 ]
Peng, Bao-gang [15 ]
Qin, Xiao [24 ]
Qiu, Yu-dong [25 ]
Wang, Guang-yi [26 ]
Wang, Yao-dong [27 ]
Wang, Zhi-ming [28 ]
Wan, Ren-hua [29 ]
Wu, Ya-fu [25 ]
Xing, Bao-cai [30 ]
Xia, Feng [31 ]
Xu, Ge-liang [9 ]
Yang, Jia-mei [3 ]
Yu, Xiao-fang [32 ]
Zeng, Yong [13 ]
Zeng, Yong-yi [33 ]
Zhang, Bi-xiang [6 ]
Zhang, Bin-hao [6 ]
Zhang, Qi-yu [34 ]
Zhang, Shui-jun [35 ]
Zhang, Wan-guang [6 ]
Zhang, Yong-jie [3 ]
机构
[1] Chinese Acad Sci, Canc Inst & Hosp, Beijing 100864, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[3] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China
[4] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Peoples R China
[5] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China
[6] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan 430030, Peoples R China
[7] Fujian Med Univ, Union Hosp, Fuzhou, Peoples R China
[8] China Med Univ, Shengjing Hosp, Beijing, Peoples R China
[9] Anhui Prov Hosp, Hefei, Peoples R China
[10] Hunan Prov Peoples Hosp, Tianjin, Peoples R China
[11] Hubei Univ Med, Taihe Hosp, Wuhan, Peoples R China
[12] Peking Univ, Peoples Hosp, Beijing, Peoples R China
[13] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
[14] Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Peoples R China
[15] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
[16] Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China
[17] Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China
[18] Harbin Med Univ, Affiliated Hosp 1, Harbin, Peoples R China
[19] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China
[20] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China
[21] Fourth Mil Med Univ, Tangdu Hosp, Xian, Peoples R China
[22] Beijing Union Med Coll Hosp, Beijing, Peoples R China
[23] Shandong Univ, Qilu Hosp, Jinan, Peoples R China
[24] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China
[25] Nanjing Drum Tower Hosp, Nanjing, Peoples R China
[26] Jilin Univ, Affiliated Hosp 1, Jilin, Peoples R China
[27] Fujian Prov Hosp, Fuzhou, Peoples R China
[28] Cent S Univ, Xiangya Hosp, Changsha, Peoples R China
[29] Nanchang Univ, Affiliated Hosp 1, Nanchang, Peoples R China
[30] Beijing Canc Hosp, Beijing, Peoples R China
[31] Third Mil Med Univ, Southwest Hosp, Chongqing, Peoples R China
[32] Shenzhen Peoples Hosp, Shenzhen, Peoples R China
[33] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China
[34] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China
[35] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[36] Fujian Prov Canc Hosp, Fuzhou, Peoples R China
关键词
PRIMARY SCLEROSING CHOLANGITIS; MAGNETIC-RESONANCE CHOLANGIOGRAPHY; EXTRAHEPATIC BILE-DUCT; SERUM TUMOR-MARKERS; HILAR CHOLANGIOCARCINOMA; INTRAHEPATIC CHOLANGIOCARCINOMA; BILIARY OBSTRUCTION; CARCINOMA; CANCER; MANAGEMENT;
D O I
10.1007/s11596-014-1301-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cholangiocarcinoma refers to malignant tumors that develop in epithelial lining of biliary system, and it is divided into two categories according to tumor location, intrahepatic cholangiocarcinoma (ICC) and extrahepatic cholangiocarcinoma (ECC). ICC occurs from the epithelial cells of the intrahepatic bile duct, its branches and interlobular biliary tree; and ECC is divided into hilar cholangiocarcinoma and distal cholangiocarcinoma by the circumscription at the confluence of cystic duct and the common hepatic duct. During the past 10 years, the incidence of cholangiocarcinoma kept increasing, in which ICC accounts for 20%-25%, hilar cholangiocarcinoma about 50%-60%, and distal extrahepatic cholangiocarcinoma about 20%-25%([1-3]). The guidelines on diagnosis and treatment of cholangiocarcinoma have been established and revised several times in past 10 years. In 2010, ICC was separated from hepatic cancer by the 7th version of TNM Staging System (American Joint Committee on Cancer, AJCC). In response to this new situation, it is necessary to develop a consensus on diagnosis and treatment of cholangiocarcinoma in China. This draft aims at summarizing the views on the diagnosis and treatment of cholangiocarcinoma of the surgical experts from more than 30 medical centers in China, and laying down a foundation for establishing a guideline on diagnosis and treatment of cholangiocarcinoma in China.
引用
收藏
页码:469 / 475
页数:7
相关论文
共 50 条
  • [1] Diagnosis and treatment of cholangiocarcinoma: A consensus from surgical specialists of China
    Jian-qiang Cai
    Shou-wang Cai
    Wen-ming Cong
    Min-shan Chen
    Ping Chen
    Xiao-ping Chen
    Yan-ling Chen
    Yi-fa Chen
    Chao-liu Dai
    Qiang Huang
    Zhi-yong Huang
    Bo Jiang
    Bin Jiang
    Ke-wei Jiang
    Bo Li
    Zong-fang Li
    Li-jian Liang
    Bin Liu
    Hui-chun Liu
    Lian-xin Liu
    Qing-guang Liu
    Rong Liu
    Ying-bin Liu
    Jian-guo Lu
    Shi-chun Lu
    Yi Lu
    Yi-lei Mao
    Bin Mei
    Jun Niu
    Bao-gang Peng
    Xiao Qin
    Yu-dong Qiu
    Guang-yi Wang
    Yao-dong Wang
    Zhi-ming Wang
    Ren-hua Wan
    Ya-fu Wu
    Bao-cai Xing
    Feng Xia
    Ge-liang Xu
    Jia-mei Yang
    Xiao-fang Yu
    Yong Zeng
    Yong-yi Zeng
    Bi-xiang Zhang
    Bin-hao Zhang
    Qi-yu Zhang
    Shui-jun Zhang
    Wan-guang Zhang
    Yong-jie Zhang
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2014, 34 : 469 - 475
  • [2] Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document
    Khan, SA
    Davidson, BR
    Goldin, R
    Pereira, SP
    Rosenberg, WMC
    Taylor-Robinson, SD
    Thillainayagam, AV
    Thomas, HC
    Thursz, MR
    Wasan, H
    GUT, 2002, 51 : 1 - 9
  • [3] Consensus of Chinese Specialists on Diagnosis and Treatment of Resistant Hypertension
    Sun Ning-Ling
    Huo Yong
    Wang Ji-Guang
    Li Nan-Fang
    Tao Jun
    Li Yong
    Yan Xiao-Wei
    Jiang Xiong-Jing
    Li Xue-Wang
    中华医学杂志英文版, 2015, 128 (15) : 2102 - 2108
  • [4] Consensus of Chinese Specialists on Diagnosis and Treatment of Resistant Hypertension
    Sun, Ning-Ling
    Huo, Yong
    Wang, Ji-Guang
    Li, Nan-Fang
    Tao, Jun
    Li, Yong
    Yan, Xiao-Wei
    Jiang, Xiong-Jing
    Li, Xue-Wang
    CHINESE MEDICAL JOURNAL, 2015, 128 (15) : 2102 - 2108
  • [5] Diagnosis and treatment of cholangiocarcinoma in Italy: A Delphi consensus statement
    Rimassa, Lorenza
    Brandi, Giovanni
    Niger, Monica
    Normanno, Nicola
    Melisi, D.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 192
  • [6] Progress in diagnosis and surgical treatment of perihilar cholangiocarcinoma
    Feng, Jia-Wei
    Yang, Xing-Hai
    Wu, Bao-Qiang
    Jiang, Yong
    Qu, Zhen
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2019, 42 (04): : 271 - 279
  • [8] Diagnosis and surgical treatment of primary hepatic cholangiocarcinoma
    Han, SL
    Zhu, GB
    Yao, JG
    Lan, SH
    Shao, YF
    HEPATO-GASTROENTEROLOGY, 2005, 52 (62) : 348 - 351
  • [9] Diagnosis and surgical treatment of hepatic hilar cholangiocarcinoma
    Yang, Wei-Liang
    Zhang, Xin-Chen
    Zhang, Dong-Wei
    Tong, Bai-Feng
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2007, 6 (06) : 631 - 635
  • [10] Diagnosis and Surgical Treatment of Intrahepatic Hepatolithiasis Associated Cholangiocarcinoma
    Han, Shao-Liang
    Zhou, Hong-Zhong
    Cheng, Jun
    Lan, Sheng-Hong
    Zhang, Pei-Chen
    Chen, Zhe-Jing
    Zeng, Qi-Qiang
    ASIAN JOURNAL OF SURGERY, 2009, 32 (01) : 1 - 6